BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call Transcript
Summarize this article with:
SA Transcripts157.33K FollowersFollow5ShareSaveCommentsQ3: 2025-12-09 Earnings SummaryPlay CallPlay CallPR10-QEPS of $0.10 misses by $0.06 | Revenue of $83.52M beats by $623.29K BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call December 9, 2025 4:30 PM EST Company Participants David DeichlerOguzhan Atay - Co-Founder, Chairman & CEORoss Taylor - Chief Financial Officer Conference Call Participants Mark Massaro - BTIG, LLC, Research DivisionAndrew Brackmann - William Blair & Company L.L.C., Research DivisionDavid Westenberg - Piper Sandler & Co., Research DivisionCasey Woodring - JPMorgan Chase & Co, Research DivisionBrandon Couillard - Wells Fargo Securities, LLC, Research DivisionTycho Peterson - Jefferies LLC, Research Division Presentation Operator BillionToOne Third Quarter 2025 Earnings Call. [Operator Instructions]. Please be advised that today's call is being recorded. I would now like to hand the call over to your speaker today, David Deichlerm Investor Relations. Please go ahead.
David Deichler Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from BillionToOne, we have Oguzhan Atay, Co-Founder and Chief Executive Officer; and Ross Taylor, Chief Financial Officer. Earlier today, BillionToOne released financial results for the third quarter ended September 30, 2025. A copy of the press release is available on the company's website. Before we begin, I want to remind you that during this call, we may make forward-looking statements within the meaning of federal securities laws. Such statements about future events may include statements about our financial outlook and performance, market size, products and services, reimbursement coverage, future clinical performance and other statements. We caution you that such statements reflect our current best judgment, and actual results may differ materially from those expressed or implied in any forward-looking statements. Risk factors that may cause our results to differ are discussed in our filings with the SEC, including our previously filed registration statement on Form S-1, our quarterly report on Form 10-Q to be filed following this call and the current report on Form 8-K Recommended For You